7 Areas That Should Be Optimized to Achieve Clinical Trial Readiness
Read this excerpt from our eBook.
Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials
We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea Therapeutics. Akcea is a development and commercialization company focused on helping patients with serious diseases. The company is based in Boston, MA. Here are some of the most interesting excerpts from our discussion:
ArcheMedX:
You’re a neurologist
Why Does Clinical Trial Readiness Matter, and How is it Used to Improve Performance?
Clinical trial readiness is an essential part of keeping the many people who participate in clinical trials safe while ensuring the trial runs smoothly, remains in compliance, and stays within budget.
ArcheMedX Stands with Those Advancing True, Meaningful Equality for All
We join our partners in celebrating Pride Month, because LGBTQ+ rights are human rights. ArcheMedX will always stand with the LBGTQ+ community, with Black Lives Matter, and with anyone who seeks to advance true, meaningful Equality for all. Read our statement in support of Pride Month here.
What Is Clinical Trial Readiness?
Clinical trial readiness has to do with building systems within a clinical trial that better prepare all project staff for the challenges and responsibilities they will face during the trial. Readiness can relate to sites, staff, and even patients — and its impact can be monumental.
Interview: COVID-19 Has Forced Clinical Research to Innovate, but We Must Do More
The COVID-19 pandemic has forced clinical research to make bold changes to survive. Pharma Initiatives’ Mark Shapiro joined ArcheMedX to discuss what changes are temporary – and what will be true disruption.
FDA’s Latest Guidance for Clinical Trials: What You Need to Know Now
On May 14, the FDA issued an update to its guidance on conducting clinical trials for medical products during the COVID-19 and ongoing public health emergency. Here’s what you need to know now.
4 Things to Do Now While Clinical Trials Are on Pause
While industry media are reporting that some clinical trials that had been paused are restarting, much of our industry remains stalled due to COVID-19. If you’re among those still in limbo, you may be struggling with how to prioritize your time right now to prepare for restarting. We’ve put together
Interview: The People-First Approach to Success in Clinical Trials
We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics, a biotech focused on the discovery and development of precision medicines for cancer. The company is based in Cambridge, MA. We wanted to share these excerpts from the conversation:
ArcheMedX:
What are the biggest and/or most common
Turning Conversation into Positive Change
Recent events have struck at the very soul of our nation. They demand nothing less than our immediate attention and swift action.
We must recognize that our Black friends, colleagues, family members, and neighbors carry an undue burden. We, society at large and each of us individually, have failed them. We
